nantradol has been researched along with Benign Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altenburg, HP; Heim, ME; Queisser, W | 1 |
| Calman, K; Cash, H; Charlton, D; Kaye, S; Milstead, R; Sangster, G; Stuart, F; Welsh, J | 1 |
| Heim, ME; Queisser, W | 1 |
| Citron, ML; Cohen, MH; Fossieck, BE; Franklin, R; Harwood, S; Herman, TS; Krasnow, SH; Vreeland, F | 1 |
1 trial(s) available for nantradol and Benign Neoplasms
| Article | Year |
|---|---|
Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Middle Aged; Nausea; Neoplasms; Phenanthridines; Random Allocation; Vomiting | 1985 |
3 other study(ies) available for nantradol and Benign Neoplasms
| Article | Year |
|---|---|
Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Phenanthridines; Random Allocation; Vomiting | 1984 |
Oral levonantradol in the control of cancer chemotherapy-induced emesis.
Topics: Antiemetics; Cisplatin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Neoplasms; Phenanthridines; Vomiting | 1983 |
[Treatment of refractory cytostatic agent-induced vomiting with the synthetic cannabinoid levonantradol].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Chemical Phenomena; Chemistry; Female; Humans; Male; Middle Aged; Neoplasms; Phenanthridines; Vomiting | 1982 |